Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19.

Abraham GR, Kuc RE, Althage M, Greasley PJ, Ambery P, Maguire JJ, Wilkinson IB, Hoole SP, Cheriyan J, Davenport AP

J Mol Cell Cardiol - (-) - [2022-03-23; online 2022-03-23]

Virus induced endothelial dysregulation is a well-recognised feature of severe Covid-19 infection. Endothelin-1 (ET-1) is the most highly expressed peptide in endothelial cells and a potent vasoconstrictor, thus representing a potential therapeutic target. ET-1 plasma levels were measured in a cohort of 194 Covid-19 patients stratified according to the clinical severity of their illness. Hospitalised patients, including those who died and those developing acute myocardial or kidney injury, had significantly elevated ET-1 plasma levels during the acute phase of infection. The results support the hypothesis that endothelin receptor antagonists may provide clinical benefit for certain Covid-19 patients.

Category: Biochemistry

Category: Health

Type: Journal article

PubMed 35339512

DOI 10.1016/j.yjmcc.2022.03.007

Crossref 10.1016/j.yjmcc.2022.03.007

pii: S0022-2828(22)00051-7
pmc: PMC8941861


Publications 7.1.2